Schirinzi, Tommaso
Maftei, Daniela
Maurizi, Riccardo
Albanese, Maria
Simonetta, Clara
Bovenzi, Roberta
Bissacco, Jacopo
Mascioli, Davide
Boffa, Laura
Di Certo, Maria Grazia
Gabanella, Francesca
Francavilla, Beatrice
Di Girolamo, Stefano
Mercuri, Nicola Biagio
Passali, Francesco Maria
Lattanzi, Roberta
Severini, Cinzia
Funding for this research was provided by:
Sapienza Università di Roma (SEED PNR (2021) “PROKINETICIN 2: a new potenzial neuroinflammatory biomarker in Alzheimer disease”)
Ministero dell'Università e della Ricerca (DSB.AD006.371 “INVECCHIAMENTO ATTIVO E IN SALUTE (FOE 2022))
Università degli Studi di Roma Tor Vergata
Article History
Received: 7 January 2024
Accepted: 29 March 2024
First Online: 4 April 2024
Declarations
:
: The study was approved by the local EC (protocol n° 16.21), following the principles of Helsinki Declaration.
: Informed consent was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for data publication.
: The authors declare no competing interests.